Madrigal Pharmaceuticals
The Thought Leader Liaison (TLL) at Madrigal Pharmaceuticals is a field‑based commercial role focused on building and maintaining relationships with academic and clinical thought leaders to support the launch of Resmetirom for MASH. The role drives brand and disease‑state strategies through thought‑leader engagement, market insight generation, and coordination of congress and speaker programs, while collaborating across cross‑functional teams.
Headquarters
Conshohocken, Pennsylvania, United States
Company Size
201-500 employees
Founded
2016
Delivering a Breakthrough Treatment Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need. Left untreated, MASH can lead to progressive liver scarring, cirrhosis, liver failure, liver cancer, need for transplant and premature mortality. Our goal is to halt or reverse […]
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Madrigal Pharmaceuticals.
21% above the average for this role
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
2 weeks ago
Thought Leader Liaison (TLL)
AstraZeneca
Thought Leader Liaison (TLL)
AstraZeneca
Associate Director, Hematology Thought Leader Liaison (TLL) Northeast
Regeneron Pharmaceuticals
Thought Leader Liaison
AstraZeneca
Marketing Director, Thought Leader Engagement Strategy
Kura Oncology
Thought Leader Liaison
AstraZeneca